FDA Approves New Treatment for Metastatic HER2 Breast CancerFDA Approves New Treatment for Metastatic HER2 Breast Cancer

Trastuzumab emtansine, also known as T-DM1, provides clinicians with another treatment option for patients who progress on trastuzumab. FDA Approvals

Source: Medscape Today Headlines - February 22, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news